Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 286554011000036115 | tetracosactide 250 microgram/mL injection, ampoule | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 286555011000036116 | tetracosactide 250 microgram / 1 mL injection, 1 mL ampoule (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| tetracosactide 250 microgram/mL injection, ampoule | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| tetracosactide 250 microgram/mL injection, ampoule | Is a | tetracosactide | true | Inferred relationship | Some | ||
| tetracosactide 250 microgram/mL injection, ampoule | has intended active ingredient | tetracosactide | true | Inferred relationship | Some | 1761477294 | |
| tetracosactide 250 microgram/mL injection, ampoule | has Australian BoSS | tetracosactide | true | Inferred relationship | Some | 1761477294 | |
| tetracosactide 250 microgram/mL injection, ampoule | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| tetracosactide 250 microgram/mL injection, ampoule | has unit of use | ampoule | true | Inferred relationship | Some | 1761477295 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Synacthen 250 microgram/mL injection, ampoule | Is a | True | tetracosactide 250 microgram/mL injection, ampoule | Inferred relationship | Some | |
| tetracosactide 250 microgram/mL injection, 1 mL ampoule | has MPUU | True | tetracosactide 250 microgram/mL injection, ampoule | Inferred relationship | Some | 1 |
Reference Sets
Medicinal product unit of use reference set
FHIR